mdl 100173 has been researched along with bradykinin in 1 studies
Studies (mdl 100173) | Trials (mdl 100173) | Recent Studies (post-2010) (mdl 100173) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
---|---|---|---|---|---|
7 | 2 | 0 | 14,195 | 355 | 1,520 |
Protein | Taxonomy | mdl 100173 (IC50) | bradykinin (IC50) |
---|---|---|---|
B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, B; Beach, DC; Dage, RC; Flynn, GA; French, JF; Giroux, EL; Koehl, JR; Mehdi, S | 1 |
1 other study(ies) available for mdl 100173 and bradykinin
Article | Year |
---|---|
Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Benzazepines; Bradykinin; Male; Molecular Structure; Neprilysin; Peptidyl-Dipeptidase A; Prodrugs; Pyridines; Rats; Rats, Sprague-Dawley | 1994 |